NCT02846103View on ClinicalTrials.gov

Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

July 27, 2022

Study Completion Date

September 14, 2023

Conditions
Lung Cancer
Interventions
OTHER

Biological samples

blood and tumor tissue samples

Trial Locations (5)

21079

CHU de Dijon, Dijon

Unknown

Centre Hospitalier Régional Universitaire de Besançon, Besançon

Centre Georges François Leclerc, Dijon

Institut Jean Godinot, Reims

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02846103 - Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer | Biotech Hunter | Biotech Hunter